Effect of Implant Treatment and/or Dietary Advice on the Nutrition of Edentulous Ageing Subjects

Does the Rehabilitation of Masticatory Function and/or Brief Dietary Advice Improve the Diet and Nutrition of Older Subjects With Terminal Dentition or Full Edentulism? A Factorial Randomized Controlled Clinical Trial

Loss of masticatory function consequent to tooth loss is associated with changes in food choices and insufficient nutrition intake. To date, studies showed no significant improvement in nutrient intake with interventions based solely on dental prostheses. Pilot studies have shown positive impacts of interventions combining implant-supported fixed dental prosthesis with brief dietary interventions. The relative contribution and the potential synergy of the components of such interventions need to be determined as it has major public health implications for the community-dwelling ageing population that continues to disproportionately suffer from tooth loss and its consequences.

This study tests the effect of rehabilitation of masticatory function with fixed implant supported dentures and diet re-education on the dietary intake and nutrition in older subjects with terminal dentition (stage IV periodontitis) or full edentulism.

A 2 × 2 factorial randomized controlled trial of eligible adult (≥60 years) with loss of masticatory function consequent to full arch edentulism or terminal dentition (n = 120) will be conducted to test whether the rehabilitation of masticatory function with fixed implant supported dentures, diet re-education and/or their combination improves the diet and nutrition of ageing subjects. The study has been designed to detect changes in fruit and vegetable intake at 4 months using the 24-hour dietary recall method. Changes in protein as percentage of total energy, nutritional biomarkers, metabolomics, oral and gut microbiome, quality of life and masticatory function will also be assessed.

Study Overview

Detailed Description

Complete edentulism or presence of a terminal dentition that is functionally compromised in an irreparable way represent the end of the spectrum of caries and periodontitis, eventually leading to loss of masticatory function. These subjects tend to show change in their diet behavior choosing softer diets with higher carbohydrates and fat and less fresh fruit and vegetables.

Accumulating evidence points to the presence of an association between changes in dietary behavior consequent to tooth loss and insufficient nutrition intake. Such impaired nutrition may have long term effects on muscle strength and physical decline, and be detrimental to general health. Indeed, the recent GBD study of dietary risk factors identifies 15 important disease associated exposures. Their analysis shows that 5 of the health associated exposures: consumption of fruit, vegetables, whole grains, nuts, and fiber require a good level of mastication.

While the physiology of mastication is an essential component of alimentation and contributes to the broader process of nutrition, a more holistic approach is needed to properly establish the scientific basis of the contribution of oral health to nutrition and healthy ageing. Assuming a potential cause-effect relationship between the inadequate food choice consequent to tooth loss and compromised nutrition intake, several studies have tried to improve the nutrient intake among edentulous individuals with various types of dentures. However, this goal has not been readily achieved with either complete denture or implant-retained overdenture, given the function limitation on these prosthesis and the lack of dietary intervention.

A small-scale case series has shown that implant-supported fixed prosthesis resulted in more efficient mastication and improved nutrient intake compared with conventional and implant-based removable dentures in partial edentulism. However, no evidence is available regarding the effect of re-establishment of masticatory function with an implant-supported fixed prosthesis in edentulous patients.

Moreover, with the increasing evidence suggesting a positive impact of nutrition counselling on the dietary intake, brief dietary advice has been advocated to help patients make full use of the enhanced masticatory function to improve their diet. Ellis et al. further showed that the impact of dietary advice on patient's satisfaction with dentures and oral health-related quality of life depends on the nature of the prosthesis. No trial has been performed to assess the benefit of dietary advice only or the combined effect of re-establishment of masticatory function with an implant-supported fixed prosthesis and dietary advice in edentulous elderly subjects.

This is a 2 × 2 factorial clinical trial aimed to assess the effect of rehabilitation of masticatory function with fixed implant supported dentures and simultaneous diet re-education on the diet intake and nutrition in ageing subjects with terminal dentition (stage IV periodontitis) or full edentulism.

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 201206
        • Recruiting
        • Shanghai Perio-Implant Innovation Center
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • being edentulous or having the presence of terminal dentition (defined as few remaining teeth insufficient in terms of number, position and health status to provide adequate anchorage to a tooth supported or a tooth retained denture) and looking for implant-supported fixed denture treatment
  • accepted treatment plan for fixed implant-supported prosthesis restoring at least 10 pairs of occluding teeth
  • self-reported inadequate vegetable or fruit or protein intakes (patients were included if at least one of the three criteria listed below were met) I. Patients with a total average daily intake of < 80 g of poultry, meat and aquatic product. II. Patients with an average daily intake of < 200 g of fruit. III. Patients with an average daily intake of < 300 g of vegetables.
  • understand written and spoken Chinese and who could respond to Chinese questionnaires
  • able and willing to give informed consent for participation in the study
  • able and willing to comply with 12-month follow-up

Exclusion Criteria:

  • general contraindications to elective oral surgery procedures
  • local contraindications to implant-supported immediate-loading fixed prosthesis (e.g. limited jaw opening, insufficient bone volumes/densities)
  • looking for replacement of existing implant-retained overdenture with implant-supported fixed denture treatment
  • presence of infectious disease, acute or chronic symptoms of TMJ disorder
  • psychiatric disorder, dementia
  • any dietary restriction, currently taking nutrient supplements or inability to choose his/her diet.
  • uncontrolled diabetes (HbA1c≥7.0%)
  • self-reported heavy smokers (>10 cigarette/day)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: GroupA(DE+/DI+)
The treatment includes the combination of implant-supported full-arch fixed prostheses (dental intervention, DE) and dietary intervention tailored to the dental status (dietary intervention, DI) without waiting period
Implant-supported full-arch fixed dental prostheses in at least one jaw and appropriate treatment in the opposing jaw regarding periodontal diseases, caries, replacement of missing teeth and soft tissue disorders to get at least 10 pairs of occluding teeth. The intervention is designed to provide rehabilitation of masticatory function.
Other Names:
  • Immediate rehabilitation of masticatory function

Dietary intervention based on the health Belief Model (HBM) with the behavioral goal of increasing an individual's likelihood of food intake regarding fresh vegetables, fresh fruits, and high quality protein for the potential intervention strategies.

Participants will receive 20 minutes' coordinated dietary advice in the form of the slideshow presentation . A pamphlet prepared with reference to the Supplementary Guidelines for Elderly Populations, the 4th edition of the Dietary Guidelines for Chinese will be given to the participant separately. If a participant does not prepare his or her own meals, the person who does the cooking receives the dietary advice as well.

Other Names:
  • Immediate dietary intervention
Active Comparator: GroupB(DE+/DI-)
The treatment includes implant-supported full-arch fixed prostheses (dental intervention, DE) without waiting period and dietary intervention tailored to the dental status (dietary intervention, DI) 4-month later
Implant-supported full-arch fixed dental prostheses in at least one jaw and appropriate treatment in the opposing jaw regarding periodontal diseases, caries, replacement of missing teeth and soft tissue disorders to get at least 10 pairs of occluding teeth. The intervention is designed to provide rehabilitation of masticatory function.
Other Names:
  • Immediate rehabilitation of masticatory function

Dietary intervention based on the health Belief Model (HBM) with the behavioral goal of increasing an individual's likelihood of food intake regarding fresh vegetables, fresh fruits, and high quality protein for the potential intervention strategies.

Participants will receive 20 minutes' coordinated dietary advice in the form of the slideshow presentation . A pamphlet prepared with reference to the Supplementary Guidelines for Elderly Populations, the 4th edition of the Dietary Guidelines for Chinese will be given to the participant separately. If a participant does not prepare his or her own meals, the person who does the cooking receives the dietary advice as well.

Other Names:
  • Delayed dietary intervention
Active Comparator: GroupC(DE-/DI+)
The treatment includes dietary intervention tailored to the dental status (dietary intervention, DI) without waiting period and implant-supported full-arch fixed prostheses (dental intervention, DE) 4-month later

Dietary intervention based on the health Belief Model (HBM) with the behavioral goal of increasing an individual's likelihood of food intake regarding fresh vegetables, fresh fruits, and high quality protein for the potential intervention strategies.

Participants will receive 20 minutes' coordinated dietary advice in the form of the slideshow presentation . A pamphlet prepared with reference to the Supplementary Guidelines for Elderly Populations, the 4th edition of the Dietary Guidelines for Chinese will be given to the participant separately. If a participant does not prepare his or her own meals, the person who does the cooking receives the dietary advice as well.

Other Names:
  • Immediate dietary intervention
Delayed (4 months) implant-supported full-arch fixed dental prostheses in at least one jaw and appropriate treatment in the opposing jaw regarding periodontal diseases, caries, replacement of missing teeth and soft tissue disorders to get at least 10 pairs of occluding teeth. The intervention is designed to provide rehabilitation of masticatory function.
Other Names:
  • Delayed rehabilitation of masticatory function
Placebo Comparator: GroupD(DE-/DI-)
The treatment included implant-supported full-arch fixed prostheses (dental intervention, DE) and dietary intervention tailored to the dental status (dietary intervention, DI) with 4-month waiting period. Only general dietary information is provided at baseline.

Dietary intervention based on the health Belief Model (HBM) with the behavioral goal of increasing an individual's likelihood of food intake regarding fresh vegetables, fresh fruits, and high quality protein for the potential intervention strategies.

Participants will receive 20 minutes' coordinated dietary advice in the form of the slideshow presentation . A pamphlet prepared with reference to the Supplementary Guidelines for Elderly Populations, the 4th edition of the Dietary Guidelines for Chinese will be given to the participant separately. If a participant does not prepare his or her own meals, the person who does the cooking receives the dietary advice as well.

Other Names:
  • Delayed dietary intervention
Delayed (4 months) implant-supported full-arch fixed dental prostheses in at least one jaw and appropriate treatment in the opposing jaw regarding periodontal diseases, caries, replacement of missing teeth and soft tissue disorders to get at least 10 pairs of occluding teeth. The intervention is designed to provide rehabilitation of masticatory function.
Other Names:
  • Delayed rehabilitation of masticatory function

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
changes in intake of fruit and vegetables
Time Frame: from baseline to 4-month
Three 24-hour dietary recall will be conducted through interview, twice on weekdays and once on weekend. The data on food consumption will be converted into the corresponding nutrient contents based on the China Food Composition Tables Standard Edition
from baseline to 4-month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nutrient intake
Time Frame: at baseline, 4, 8, 12 and 16 months
The intake of fruit and vegetables, protein% of total energy according to a modified version of food-frequency questionnaire
at baseline, 4, 8, 12 and 16 months
Masticatory function
Time Frame: at baseline, 4, 8, 12 and 16 months
Ability to mix a two-color chewing gum with 20 masticatory cycles. The obtained bolus will be pressed to a standardized height and a color image will be acquired. Quantitative data will be obtained by digital analysis of the image using variance of hue as the outcome
at baseline, 4, 8, 12 and 16 months
Peri-implant oral hygiene
Time Frame: at 4, 8, 12 and 16 months for groups with implants
Modified plaque index (mPI) measured by periodontal probing
at 4, 8, 12 and 16 months for groups with implants
Peri-implant soft and hard tissue health (probing depth)
Time Frame: at 4, 8, 12 and 16 months for groups with implants
Peri-implant probing depth (PD) measured by periodontal probing
at 4, 8, 12 and 16 months for groups with implants
Peri-implant soft and hard tissue health (local inflammation)
Time Frame: at 4, 8, 12 and 16 months for groups with implants
Peri-implant modified bleeding index (mBI) measured by periodontal probing
at 4, 8, 12 and 16 months for groups with implants
Peri-implant radiographic bone level stability
Time Frame: 4, and 12 months after dental implant placement (in the context of standard care)
Standardized panoramic radiographic imaging will be conducted to assess the peri-implant bone level.
4, and 12 months after dental implant placement (in the context of standard care)
OHIP-14 questionnaire
Time Frame: at baseline, 4, 8, 12 and 16 months
the impact of oral health on the quality of life of participants assessed with the oral health impact profile (OHIP)-14. A 5-point scale was used to calculate the score for each of 14 items. The total score of OHIP-14 is in the range of 0 to 56 with higher values indicating more frequent impacts
at baseline, 4, 8, 12 and 16 months
Metabolism and systemic inflammatory biomarkers (i)
Time Frame: at baseline, 4, 8, 12 and 16 months
blood plasma concentration of homocysteine (gas chromatography)
at baseline, 4, 8, 12 and 16 months
Metabolism and systemic inflammatory biomarkers (ii)
Time Frame: at baseline, 4, 8, 12 and 16 months
Plasma hs-CRP assessed by immunoturbidometry
at baseline, 4, 8, 12 and 16 months
Metabolism and systemic inflammatory biomarkers (iii)
Time Frame: at baseline, 4, 8, 12 and 16 months
Plasma TNF-α (ELISA)
at baseline, 4, 8, 12 and 16 months
Metabolism and systemic inflammatory biomarkers (iv)
Time Frame: at baseline, 4, 8, 12 and 16 months
Plasma IL-1β (ELISA)
at baseline, 4, 8, 12 and 16 months
Metabolism and systemic inflammatory biomarkers (v)
Time Frame: at baseline, 4, 8, 12 and 16 months
Plasma IL-6 (ELISA)
at baseline, 4, 8, 12 and 16 months
Oxidative stress biomarkers (i)
Time Frame: at baseline, 4, 8, 12 and 16 months
Plasma Co Q10 with liquid chromatography-mass spectrometry
at baseline, 4, 8, 12 and 16 months
Oxidative stress biomarkers (ii)
Time Frame: at baseline, 4, 8, 12 and 16 months
Plasma uric acid (the enzymatic method)
at baseline, 4, 8, 12 and 16 months
Oxidative stress biomarkers (iii)
Time Frame: at baseline, 4, 8, 12 and 16 months
Plasma superoxide dismutase (the chemical colorimetric method)
at baseline, 4, 8, 12 and 16 months
Nutritional biomarker(Plasma vitamin A)
Time Frame: at baseline, 4, 8, 12 and 16 months
concentration of plasma vitamin A assessed by liquid chromatography-mass spectrometry
at baseline, 4, 8, 12 and 16 months
Nutritional biomarker(Plasma vitamin B2)
Time Frame: at baseline, 4, 8, 12 and 16 months
concentration of plasma vitamin B2 assessed by liquid chromatography-mass spectrometry
at baseline, 4, 8, 12 and 16 months
Nutritional biomarker(Plasma vitamin B12)
Time Frame: at baseline, 4, 8, 12 and 16 months
concentration of plasma vitamin B12 assessed by liquid chromatography-mass spectrometry
at baseline, 4, 8, 12 and 16 months
Nutritional biomarker(Plasma folate)
Time Frame: at baseline, 4, 8, 12 and 16 months
concentration of plasma folate assessed by liquid chromatography-mass spectrometry
at baseline, 4, 8, 12 and 16 months
Nutritional biomarker(Plasma vitamin C)
Time Frame: at baseline, 4, 8, 12 and 16 months
concentration of plasma vitamin C assessed by liquid chromatography-mass spectrometry
at baseline, 4, 8, 12 and 16 months
Nutritional biomarker(Plasma vitamin E)
Time Frame: at baseline, 4, 8, 12 and 16 months
concentration of plasma vitamin E assessed by liquid chromatography-mass spectrometry
at baseline, 4, 8, 12 and 16 months
Nutritional biomarker(plasma α-carotene)
Time Frame: at baseline, 4, 8, 12 and 16 months
concentration of plasma α-carotene assessed by liquid chromatography-mass spectrometry
at baseline, 4, 8, 12 and 16 months
Nutritional biomarker(plasma β-carotene)
Time Frame: at baseline, 4, 8, 12 and 16 months
concentration of plasma α-carotene assessed by liquid chromatography-mass spectrometry
at baseline, 4, 8, 12 and 16 months
Nutritional biomarker(plasma β-cryptoxanthin)
Time Frame: at baseline, 4, 8, 12 and 16 months
concentration of plasma β-cryptoxanthin assessed by liquid chromatography-mass spectrometry
at baseline, 4, 8, 12 and 16 months
Nutritional biomarker(plasma lycopene)
Time Frame: at baseline, 4, 8, 12 and 16 months
concentration of plasma lycopene assessed by liquid chromatography-mass spectrometry
at baseline, 4, 8, 12 and 16 months
Nutritional biomarker(plasma lutein/zeaxanthin)
Time Frame: at baseline, 4, 8, 12 and 16 months
concentration of plasma lutein/zeaxanthin assessed by liquid chromatography-mass spectrometry
at baseline, 4, 8, 12 and 16 months
Nutritional biomarker(plasma α-tocopherols)
Time Frame: at baseline, 4, 8, 12 and 16 months
concentration of plasma α-tocopherols assessed by liquid chromatography-mass spectrometry
at baseline, 4, 8, 12 and 16 months
Nutritional biomarker(plasma γ-tocopherols)
Time Frame: at baseline, 4, 8, 12 and 16 months
concentration of plasma γ-tocopherols assessed by liquid chromatography-mass spectrometry
at baseline, 4, 8, 12 and 16 months
Nutritional biomarker(Plasma total cholesterol)
Time Frame: at baseline, 4, 8, 12 and 16 months
concentration of plasma total cholesterol (Enzymatic Measurements)
at baseline, 4, 8, 12 and 16 months
Nutritional biomarker(Plasma HDL cholesterol)
Time Frame: at baseline, 4, 8, 12 and 16 months
concentration of plasma HDL cholesterol (Enzymatic Measurements)
at baseline, 4, 8, 12 and 16 months
Nutritional biomarker(Plasma LDL cholesterol)
Time Frame: at baseline, 4, 8, 12 and 16 months
concentration of plasma LDL cholesterol (Enzymatic Measurements)
at baseline, 4, 8, 12 and 16 months
Nutritional biomarker(Plasma triglycerides)
Time Frame: at baseline, 4, 8, 12 and 16 months
concentration of plasma triglycerides (Enzymatic Measurements)
at baseline, 4, 8, 12 and 16 months
Nutritional biomarker(Plasma Lpa)
Time Frame: at baseline, 4, 8, 12 and 16 months
concentration of plasma Lpa (Enzymatic Measurements)
at baseline, 4, 8, 12 and 16 months
Metabolomics (Metabolites)
Time Frame: at baseline, 4, 8, 12 and 16 months
Profiling of annotated plasma metabolites (Differential plasma metabolites with P-value< 0.05 and fold change≥2 or FC≤0.5) based on untargeted metabolomics using liquid chromatography coupled with mass spectrometry analyses
at baseline, 4, 8, 12 and 16 months
Metabolomics (Oxylipidomics)
Time Frame: at baseline, 4, 8, 12 and 16 months
Profiling of annotated plasma lipid metabolites (Differential lipid metabolites with P-value< 0.05 and fold change≥2 or FC≤0.5) based on untargeted metabolomics using liquid chromatography coupled with mass spectrometry analyses
at baseline, 4, 8, 12 and 16 months
Microbiome Analysis(saliva)
Time Frame: at baseline, 4, 8, 12 and 16 months
Taxonomic profiling with 16S rRNA gene sequencing in saliva samples
at baseline, 4, 8, 12 and 16 months
Microbiome Analysis(plaque)
Time Frame: at baseline, 4, 8, 12 and 16 months
Taxonomic profiling with 16S rRNA gene sequencing in subgingival plaque samples
at baseline, 4, 8, 12 and 16 months
Microbiome Analysis(stool)
Time Frame: at baseline, 4, 8, 12 and 16 months
Taxonomic profiling with 16S rRNA gene sequencing in stool samples
at baseline, 4, 8, 12 and 16 months
Nutritional status
Time Frame: at baseline, 4, 8, 12 and 16 months
assessment by Mini-nutrient status form with a score of 12-14 corresponding to normal nutritional status;8-11 at risk of malnutrition;0-7 malnourished
at baseline, 4, 8, 12 and 16 months
Muscle strength
Time Frame: at baseline, 4, 8, 12 and 16 months
muscle strength assessed by Hand grip dynamometer
at baseline, 4, 8, 12 and 16 months
Cognitive function(i)
Time Frame: at baseline, 4, 8, 12 and 16 months
cognitive function assessed with the Mini-Mental State Examination with a total score of 30. Score 27-30: normal cognition;Score 21-26: mild cognitive impairment;Score 10-20: moderate cognitive impairment;Score <10: severe cognitive impairment
at baseline, 4, 8, 12 and 16 months
Cognitive function(ii)
Time Frame: at baseline, 4, 8, 12 and 16 months
dementia screening with the Alzheimer's disease eight-item tool. With Score 0: no cognitive impairment, Score 1-2: cognitive impairment; Score>=3: dementia
at baseline, 4, 8, 12 and 16 months
Depression symptoms
Time Frame: at baseline, 4, 8, 12 and 16 months
assessment with the shortened Center for Epidemiologic Studies Depression Scale. The total score is the sum of 10 items. A score equal to or above 10 is considered depressed.
at baseline, 4, 8, 12 and 16 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maurizio Tonetti, DMD,PhD, Shanghai Perioimplant Innovation Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 18, 2022

Primary Completion (Estimated)

April 30, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

April 5, 2022

First Submitted That Met QC Criteria

April 12, 2022

First Posted (Actual)

April 19, 2022

Study Record Updates

Last Update Posted (Estimated)

November 22, 2023

Last Update Submitted That Met QC Criteria

November 20, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontitis

Clinical Trials on Implant-supported full-arch fixed dental prostheses(dental intervention,DE)

Subscribe